Kiniksa Pharmaceuticals International, plc (KNSA) Operating cash flow 2017–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$138.0MFY2025 · since FY2017: -$50.2M → $138.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $138.0M | +437.1% |
| FY2024 | $25.7M | +93.1% |
| FY2023 | $13.3M | +129.1% |
| FY2022 | $5.8M | +104.6% |
| FY2021 | -$126.3M | +7.5% |
| FY2020 | -$136.5M | +13.8% |
| FY2019 | -$158.4M | -95.5% |
| FY2018 | -$81.0M | -61.3% |
| FY2017 | -$50.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice